Your browser doesn't support javascript.
Disparities in Cancer Prevention in the COVID-19 Era.
Carethers, John M; Sengupta, Rajarshi; Blakey, Rea; Ribas, Antoni; D'Souza, Gypsyamber.
  • Carethers JM; Departments of Internal Medicine and Human Genetics and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan. jcarethe@umich.edu.
  • Sengupta R; American Association for Cancer Research, Philadelphia, Pennsylvania.
  • Blakey R; Oncology Center of Excellence, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Ribas A; Departments of Medicine, Surgery, and Molecular and Medical Pharmacology, and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • D'Souza G; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Cancer Prev Res (Phila) ; 13(11): 893-896, 2020 11.
Article in English | MEDLINE | ID: covidwho-1093891
ABSTRACT
Screening for cancer is a proven and recommended approach to prevent deaths from cancer; screening can locate precursor lesions and/or cancer at early stages when it is potentially curable. Racial and ethnic minorities and other medically underserved populations exhibit lower uptake of cancer screening than nonminorities in the United States. The COVID-19 pandemic, which disproportionately affected minority communities, has curtailed preventive services including cancer screening to preserve personal protective equipment and prevent spread of infection. While there is evidence for a rebound from the pandemic-driven reduction in cancer screening nationally, the return may not be even across all populations, with minority population screening that was already behind becoming further behind as a result of the community ravages from COVID-19. Fear of contracting COVID-19, limited access to safety-net clinics, and personal factors like, financial, employment, and transportation issues are concerns that are intensified in medically underserved communities. Prolonged delays in cancer screening will increase cancer in the overall population from pre-COVID-19 trajectories, and elevate the cancer disparity in minority populations. Knowing the overall benefit of cancer screening versus the risk of acquiring COVID-19, utilizing at-home screening tests and keeping the COVID-19-induced delay in screening to a minimum might slow the growth of disparity.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Healthcare Disparities / Early Detection of Cancer / Pandemics Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Cancer Prev Res (Phila) Journal subject: Neoplasms Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Healthcare Disparities / Early Detection of Cancer / Pandemics Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Cancer Prev Res (Phila) Journal subject: Neoplasms Year: 2020 Document Type: Article